Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
It is pretty nigh impossible to take Varaprasad Reddy out for a meal. Friends have tried. So has Alain Merieux, chairman of the venerable French pharmaceuticals company M
PB Jayakumar / Mumbai January 11, 2010, 0:21 IST Swiss drug manufacturer Novartis AG has been granted patent protection in India for Nilotinib, a superior version of blood cancer drug Gleevec (imatinib mesylate). It has been engaged in a legal battle with the government on the latter
Deal Could Be Aimed At Getting Access To Technology Or Manufacturing Platform Khomba Singh NEW DELHI RANBAXY Laboratories has started discussions to buy a privately held Bangalore-based vaccine company, two persons familiar with the development said. While the identity of the company could not be ascertained one of persons said …
Novartis yesterday underlined its determination to expand beyond its core drugs business, but denied that spending $50bn on Alcon put it in the same category as other pharmaceuticals groups diversifying to counter falling drug discovery rates or looming patent expiries. "This is not a diversification, it's a strengthening of our …
When one of the top 20 pharma giants in the world, Eisai Pharmaceuticals of Japan, inaugurated its global research and development and production facility in Visakhapatnam last month, it was not just another feather in the cap of the city that is being dubbed as the
The fi rst report of the Mashelkar Committee on patent issues was accused of plagiarism and the committee was asked by the government to rexamine its recommendations. The second report of this committee poses a different set of problems. This article argues that the revised recommendations are not warranted by …
Dabur, Godrej Sara Lee plans in place to grow naturals variants. The mosquito repellent cream category has become active this season with both Dabur and Godrej Sara Lee planning to grow the category based on the
Patancheru, near Hyderabad, India, is a major production site for the global bulk drug market. Approximately 90 manufacturers send their wastewater to a common treatment plant in Patancheru. Extraordinary high levels of a wide range of pharmaceuticals have recently been demonstrated in the treated effluent. As little as 0.2% of …
Very high levels of a range of pharmaceuticals have been reported recently in the effluent from a wastewater treatment plant near Hyderabad, India. The plant serves approximately 90 manufacturers of bulk drugs that primarily are exported to the world market. Fluoroquinolone antibiotics were found at levels that are highly toxic …
Two pharmaceutical companies have sought permission from the Indian Council of Medical Research to start clinical trials for swine flu vaccine prepared by them using a new method.
Indian drug major Cipla has launched generic versions of anti-flu drugs oseltamivir and zanamivir in the local market to treat the H1N1 influenza, which is spreading across the globe and in India. Cipla will brand oseltamivir in the local market as Antiflu and zanamivir as Virenza. Antiflu will cost Rs …
THE race among Indian pharma companies engaged in swine flu vaccine development may soon throw up a winner just when the pandemic enters a critical stage with the onset of winter. Drug Controller General (India) Dr Surindra Singh told ET that the Rs 3,000-crore pharma major Zydus Group has become …
Netherlands Takes Lead After India Threatens To Drag EU To WTO Amiti Sen NEW DELHI PHARMA exports from India are likely to be promised safe passage by the European Union after India took up the issue following seizure of two consignments while in transit through the region. The EU had …
MM SHARMA HEAD, COMPETITION LAW PRACTICE VAISH ASSOCIATES THE RECENT ANTI-TRUST RAIDS ON Ranbaxy's France unit by the European Commission (EC) has not come as a surprise, given that most pharmaceutical companies in India manufacture generic drugs. These drugs contain same active ingredients as the original formulations invented by the …
